Marianne Mancini's holdings are tied to her substantial role at Viking Therapeutics, where her stock ownership has evolved significantly. As of 2023, her vested stock options are valued at over $1.6 million. In previous years, her insider trading activity has...

Marianne Mancini's holdings are tied to her substantial role at Viking Therapeutics, where her stock ownership has evolved significantly. As of 2023, her vested stock options are valued at over $1.6 million. In previous years, her insider trading activity has shown impressive fluctuations, peaking in 2024 when her holdings jumped to an estimated value of $26.03 million in March. This growth reflects the company's strong performance and the potential of its drug pipeline, indicating that her financial well-being is closely linked to Viking's success. Her gradual accumulation of stock, combined with strategic grants, positions her holdings as a significant part of her overall compensation.